Health

  • August 20, 2026

    Canadian Bioscience Cos. Settle 'Fake' Fuel Trading Suit

    A Colorado state judge agreed to issue a stay and administratively close a case brought by two Canadian bioscience companies alleging that a Denver resident defrauded them out of nearly $1 million through "fake" fuel trading deals, amid an undisclosed agreement reached between the parties.

  • August 20, 2026

    Colo. Panel Says Pretrial Meeting Didn't Affect Med Mal Trial

    A Colorado state appeals court on Thursday rejected a man's bid for a new trial in his medical malpractice lawsuit in which jurors sided with his physicians, finding the man did not show that an ex parte meeting between defense counsel and his own surgeon affected the trial's outcome.

  • August 20, 2026

    Judge Denies Bid To Move AT&T ERISA Case To State Court

    A California federal judge has denied a former AT&T employee's bid to move his class action suit alleging violations of state labor law over a tobacco surcharge on employee health plans from federal to state court.

  • August 20, 2026

    DOJ Pot Shift Changes LA Licensing Challenge, 9th Circ. Told

    A California attorney who has challenged state and local cannabis licensing policies across the country on the grounds that they discriminate against out-of-state entrants told the Ninth Circuit that recent federal shifts on medical marijuana mean the dormant commerce clause should apply to the once-federally illicit industry.

  • August 20, 2026

    Amgen Reaches Deal To End Ex-Worker's Tobacco Fee Fight

    Biotech giant Amgen Inc. struck a deal to end a proposed class action alleging a $150-a-month fee on the health plans of employees who used tobacco violated federal benefits law, according to a filing in California federal court Thursday.

  • August 20, 2026

    Johns Hopkins Hit With Sex Discrimination, Retaliation Suit

    Johns Hopkins University was hit with a complaint in California federal court alleging it impaired a graduate student's educational access and retaliated against her after she returned from a pregnancy-related leave and accused her former adviser of sexual misconduct.

  • August 20, 2026

    Sangamo Ch. 11 Auction Nets $238M In Offers

    A Delaware bankruptcy judge Thursday agreed to approve a trio of sales that will bring in $52 million in cash for Sangamo Therapeutics, after attorneys representing the life sciences group told the court a competitive Chapter 11 auction ended with four winning bids worth over $238 million.

  • August 20, 2026

    UnitedHealthcare Beats User's Data Privacy Suit, For Good

    UnitedHealthcare Services Inc. permanently beat a proposed class action alleging that its website's third-party tracking pixels shared information about its visitors, after a California federal judge said Wednesday that "the mere collection of plaintiff's generic insurance browsing data is not enough to demonstrate" concrete injury.

  • August 20, 2026

    Dentons Hires Longtime K&L Gates Healthcare Lawyer

    Dentons has hired a K&L Gates LLP healthcare partner and office managing partner who spent more than 17 years at that firm advising pharmaceutical, biotechnology, medical device and other life sciences clients on regulatory, compliance and transactional matters.

  • August 20, 2026

    Rising Star: Alston & Bird's Emily McGowan

    Emily McGowan of Alston & Bird LLP has advised UnitedHealth Group's subsidiaries on several cases, including representing UnitedHealthcare in a complaint alleging that it violated the False Claims Act and representing OptumRx in opioid-related litigation, earning her a spot among the healthcare law practitioners under age 40 honored by Law360 as Rising Stars.

  • August 20, 2026

    Taco Bell Cyclospora Suit Frozen Amid Similar Cases

    A Michigan federal judge Thursday paused filings for a lawsuit alleging Taco Bell and produce supplier Taylor Farms distributed and served contaminated lettuce that caused multiple cyclospora infections.

  • August 20, 2026

    Insurer Can't Add McLaren Flint To Legionella Coverage Suit

    A Michigan federal judge said an insurer cannot add a Michigan hospital's Flint-based subsidiary to a coverage dispute stemming from legionella contamination claims, ruling Thursday that the insurer missed an agreed-upon deadline and that adding a new defendant now would disrupt the case.

  • August 20, 2026

    NY Hospital To Pay $3M In Suit Over Retirement Plan Roster

    A Long Island hospital will pay $3 million to close a suit claiming it failed to trim pricey and underperforming investment funds from its retirement plan, costing workers millions of dollars in savings, according to a filing in New York federal court.

  • August 19, 2026

    5th Circ. Tells FDA To 'Rethink' Rule Behind E-Cig Rejection

    The Fifth Circuit on Wednesday agreed with vaping companies that the U.S. Food and Drug Administration overstepped its authority when it repeatedly blocked approval of flavored e-cigarettes without a notice-and-comment period, holding that the repeated denials constitute a rule that the agency must "rethink" or readopt properly.

  • August 19, 2026

    Nonprofits Urge Court To Block HHS From Sharing Aid Data

    Counsel for a group of nonprofits on Wednesday asked a Brooklyn federal judge to block the U.S. Department of Health and Human Services from sharing personal information, including immigration status, of recipients of financial assistance with the Department of Homeland Security and other agencies, saying the proposed disclosure has "no statutory authority whatsoever."

  • August 19, 2026

    Colo. Sues GEO Group To Allow Tuberculosis Probe At ICE Camp

    Colorado sued private prison operator GEO Group in state court Wednesday, accusing it of failing to comply with a public health order seeking compliance with a tuberculosis investigation in the only immigration detention camp in the state.

  • August 19, 2026

    1st Circ. Says Apellis Disclosures Weren't 'Half-Truths'

    A First Circuit panel on Wednesday affirmed the dismissal of a securities fraud lawsuit accusing Apellis Pharmaceuticals and some of its top executives of misleading investors about the safety testing of the company's eye drug Syfovre, finding no actionable claim the company told "half-truths" about potential side effects of inflammation that can lead to blindness. 

  • August 19, 2026

    Albertsons Says Wash. Failed To Prove Opioid Claims At Trial

    Albertsons Cos. Inc. urged a Seattle judge on Tuesday to throw out Washington state's lawsuit accusing the chain and its subsidiary Safeway Inc. of fueling Washington's opioid crisis, arguing that the state failed to prove wrongdoing by the companies after nearly five weeks of an ongoing bench trial.

  • August 19, 2026

    Outcome Health Execs Owe $270M And Counting For Fraud

    Former Outcome Health executives who were convicted of a $1 billion fraud against investors, lenders and customers must repay $270.8 million to certain victims, though that amount will climb higher with additional calculation, an Illinois federal judge said Wednesday.

  • August 19, 2026

    FTC Asks Court To Keep Trans Health Suit In Texas

    The Federal Trade Commission has asked a Texas federal court to keep its suit against the World Professional Association for Transgender Health in the Lone Star State, saying that the organization incorporated there in 1980.

  • August 19, 2026

    HHS, USDA Must Withdraw Dietary Guidelines, DC Court Told

    A public health nonprofit on Wednesday urged a D.C. federal court to order the federal government to withdraw dietary guidelines it issued earlier this year, arguing that reviewers who advised on the guidelines had significant conflicts of interest and were selected without public oversight.

  • August 19, 2026

    Medtronic, Former Exec Settle Whistleblower Retaliation Suit

    A Colorado state judge tossed a whistleblower lawsuit against Medtronic Inc., granting a dismissal bid from the company and a former executive after they reached an undisclosed settlement.

  • August 19, 2026

    6th Circ. Backs Blue Cross Over Reimbursement Rate Dispute

    The Sixth Circuit on Wednesday upheld Blue Cross Blue Shield of Michigan's defeat of a lawsuit alleging it shortchanged several medical providers despite promising higher reimbursement rates before a La-Z-Boy employee received care, ruling the providers' claims were superseded by federal benefits law.

  • August 19, 2026

    Mich. Judge Is Torn Over Data Tracking Suit

    A Michigan judge tasked with deciding whether to dismiss a proposed class action against state healthcare facilities alleging improper use of data tracking tools on Wednesday told attorneys that he could not remember a case in which supporting decisions were divided so evenly.

  • August 19, 2026

    Trump Taps White House Aide Overton To Lead FDA

    President Donald Trump on Wednesday announced the nomination of White House aide Heidi Overton, an abortion opponent who has urged states to roll back vaccine requirements, to lead the U.S. Food and Drug Administration.

Expert Analysis

  • DOJ Healthcare Declination Offers Self-Disclosure Checklist

    Author Photo

    The U.S. Department of Justice's declination of criminal charges against Campus Eye Management signals that its new self-disclosure policy provides a real path for healthcare companies to avoid criminal exposure, but that path is paved with speed, transparency and operational remediation, says Jonathan Porter at Husch Blackwell.

  • Series

    Being In A Band Made Me A Better Lawyer

    Author Photo

    Playing shows in storied New York City venues and rehearsing with my bandmates in poorly ventilated rooms helped develop the professional qualities I rely on as a litigator, including an ability to collaborate with strong-minded equals and the determination to treat each client with singular focus, says Eliad Shapiro at Herrick Feinstein.

  • Opinion

    Correctional Healthcare Requires Clearer Legal Standards

    Author Photo

    As the correctional healthcare industry increasingly faces financial instability due to litigation, the U.S. Bureau of Prisons should develop clear standards for constitutionally adequate care for incarcerated patients, says Susanne Moore at Blackstone Trial Group.

  • Mich. Ruling Gives Consumer Protection Law Its Teeth Back

    Author Photo

    The Michigan Supreme Court's recent decision in Attorney General v. Eli Lilly, overruling key holdings in two earlier cases, means that Michigan businesses can no longer defeat allegations of deceptive conduct under the state's consumer protection law simply by pointing to any governmental regulation of the business, say attorneys at DiCello Levitt.

  • Series

    Law School's Missed Lessons: Surviving A Long Trial

    Author Photo

    Most of law school trial advocacy is geared toward the sprint of trying a short case, but beyond managing a cross-examination or closing argument, effectively handling the marathon of a lengthy trial requires the ability to maintain composure, organization and credibility with the jury, says Mihir Elchuri at Hirschler.

  • AI Chatbot's Medical Claims Highlight Enforcement Risks

    Author Photo

    The Pennsylvania State Board of Medicine's recent lawsuit against Character Technologies, arguing that an artificial intelligence chatbot engaged in the unlicensed practice of medicine, may provide other state licensing boards with a road map for going after AI platforms, and counsel should advise clients to calibrate compliance accordingly, say attorneys at Cooley.

  • 7th Circ. Ruling May Reduce Litigation Risk For Text Marketers

    Author Photo

    The recent Seventh Circuit holding in Steidinger v. Blackstone Medical Services that unwanted marketing text messages are not telephone calls under the Telephone Consumer Protection Act may strengthen companies' responses to presuit demand letters and early-stage litigation claims premised on do-not-call text theories, say attorneys at Holland & Knight.

  • How Calif. Ruling Defines Drug Cos.' R&D Responsibilities

    Author Photo

    The California Supreme Court's recent ruling in the Gilead Tenofovir Cases, which held that drugmakers have no duty to bring allegedly safer alternatives to market more quickly, is a win for pharmaceutical companies — but not a grant of blanket immunity for all early-stage drug development decisions, say attorneys at King & Spalding.

  • Calif. Justices' Ruling Reshapes Midcase Appeal Strategy

    Author Photo

    The California Supreme Court's recent decision in Maniago v. Desert Cardiology Consultants holds that voluntary dismissal cannot be used as a shortcut to appellate review of interlocutory orders, resolving a long-running appellate split and pushing litigants to use alternative procedural tools, says Josh Patashnik at Ashurst Perkins Coie.

  • Midyear Trends, Takeaways As Securities Class Actions Surge

    Author Photo

    High numbers of securities class actions through June suggest filings will stay elevated, with factors like changing enforcement attitudes, media scrutiny and the proliferation of potential defendants serving as both cause and effect in increased litigation involving AI-related disclosures, health and tech companies, and foreign issuers, say attorneys at Alston & Bird.

  • Series

    Going To Hardcore Shows Makes Me A Better Lawyer

    Author Photo

    While government contracts law and the hardcore scene may seem entirely unrelated, in my experience, both are about community, focus, being prepared for the unexpected and managing chaos, says Isaac Natter at Fluet.

  • Brace For Expanding Scrutiny Of Dark Patterns In Healthcare

    Author Photo

    Recent reporting and regulatory developments highlight growing concern surrounding so-called dark patterns in healthcare — user interface designs that improperly influence consumer decision-making — and represent an important evolution of how healthcare professionals should evaluate consent processes, say attorneys at Clark Hill.

  • How Home Infusion Providers Can Adapt To Enrollment Pause

    Author Photo

    Recent Centers for Medicare & Medicaid Services moratoria on new enrollments of home health agencies, medical equipment companies and hospices make home infusion providers' compliance obligations more complex and ambiguous, requiring new careful consideration of specific enrollment requirements and limitations, say attorneys at Quarles & Brady.

  • AI Data Mining Is Changing FCA Enforcement

    Author Photo

    With False Claims Act investigations increasingly emerging from statistical anomalies identified by data miners, companies need to consider what conclusions an outsider armed with artificial intelligence might draw from public-facing data and be ready to explain any anomalies if questions arise, say attorneys at Cohen & Gresser.

  • Lessons From 5 Months Of DOJ Corporate Policy Deals

    Author Photo

    Recent declinations and prosecution agreements between the U.S. Department of Justice and corporations since the March unveiling of the corporate enforcement and voluntary disclosure policy provide takeaways for management considering how to respond to corporate misconduct, says Brendan Quigley at Baker Botts.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here